<DOC>
	<DOCNO>NCT02362984</DOCNO>
	<brief_summary>This prospective , randomize , double-blind , control clinical study investigate effect DLBS1033 conjunction standard therapy compare standard therapy alone acute ischemic stroke patient .</brief_summary>
	<brief_title>DLBS1033 Treatment Acute Ischemic Stroke</brief_title>
	<detailed_description>Patients include study randomize two group receive either standard therapy alone ( control group ) standard therapy plus DLBS1033 dose 490 mg three time daily ( DLBS1033 group ) . Standard therapy use study consist : aspirin 80 mg , simvastatin 20 mg , vitamin B complex , citicholine 250 mg/2 mL twice daily . After hospital admission diagnosis , patient handle accord standard management acute ischemic stroke applicable hospital . Right patient confirm eligible study , treatment ( ) switch immediately study 's regimen . Clinical laboratory examination evaluate investigational drug 's efficacy perform baseline , day 4 , day 8 treatment ( end study ) ; safety examination perform baseline end study .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>Male female subject age 1875 year . Has diagnose acute ischemic stroke clinically confirm CT scan . Modified National Institutes Health Stroke Scale ( mNIHSS ) score &gt; = 5 . Patients present hospital receive first dose study medication within 72 hour onset stroke symptom . Able take oral medication . For female childbearing potential : pregnancy lactation period . History current hemorrhagic stroke ( within last 3 month ) . Transient ischemic stroke ( TIA ) . Patients seizure onset stroke . History serious head injury within last 3 month . History major surgery within last 3 month . Serious cardiovascular condition , myocardial infarction , CHF grade III IV ( NYHA classification ) , aorta dissection , atrial fibrillation within last 6 month . Presence severe renal hepatic dysfunction Presence acute chronic infection . Thrombocytopenia ( thrombocyte level &lt; 150.000/ul ) . Patients high risk bleed . Uncontrolled hypertension ( systolic blood pressure &gt; 185 mmHg diastolic blood pressure &gt; 110 mmHg ) . Random plasma glucose &gt; = 200 mg/dL . Current regular use oral anticoagulant , antiplatelets study medication , herbal medicine . Hypersensitive investigational product ( ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>DLBS1033</keyword>
	<keyword>acute ischemic stroke</keyword>
	<keyword>MRS</keyword>
	<keyword>mNIHSS</keyword>
</DOC>